What Changes When One System Runs Both the Denial and the Appeal
Cohere Health recently expanded its Cohere Unify platform beyond prior authorization into appeals, care management, claims operations, and quality. The expansion is built on a clinical intelligence system already supporting more than 15 million annual clinical decisions across 4,500 clinical policies and 100,000 clinical indications. The announcement describes new capabilities. It says less about what happens once those capabilities run on the same system.
This Has Already Happened Before
An organization handling both prior authorization and the appeal of that authorization is not new. EviCore has operated this way for years, conducting the initial utilization review and the first-level appeal through its own provider portal, under its own clinical guidelines, without requiring providers to return to the health plan to start the appeals process. What distinguished that arrangement was that the review at each stage still came from a distinct evaluation, even inside the same company.
That distinction showed up in how the roles were structured. A first-level appeal reviewer working from the same portal as the original UM reviewer still had to independently apply clinical guidelines to the case in front of them, not simply confirm what the first reviewer already concluded. The company running both steps didn't collapse them into one step. It kept them procedurally separate even while keeping them administratively close.
The Same Reasoning, Twice
Cohere's version of this arrangement runs differently. Its appeals component identifies the evidence most likely to affect a determination by drawing on the same clinical intelligence system used to generate the original authorization decision. The appeal isn't a separate act of reasoning anymore. It's the same reasoning, applied a second time.
Cohere's own materials note that this process now runs in about half the usual review time. It starts from reasoning the system has already produced rather than conducting an independent evaluation from the clinical record.
What Made the Appeal Work
What protected the appeal wasn't which company ran it. It was that the reasoning behind it wasn't required to match the reasoning behind the original decision, even when the same company ran both.
Once the same clinical intelligence system produces both the authorization and the review of that authorization, that protection is gone. The appeal isn't a second look anymore. It's the first system confirming its own conclusion, using the same policies and the same indications it already applied once.
The Prior Auth Report launches in late July with ongoing analysis of payer behavior, workflow burden, and the operational patterns emerging underneath prior authorization transparency data.
If you want structured analysis delivered directly to your inbox as this reporting landscape evolves, the newsletter waitlist is below.